4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-21-012901
Chief Executive Officer bought 4,000 shares at $5.38 ($21,520)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Ronald Kirk Chief Executive Officer | 2021-05-25 | Purchase | +4,000 | $5.38 | $21,520 | 5,500 | D |
| Open-market purchases · 4,000 sh · avg $5.38 · $21,520 | |||||||
Loading xslF345X03/ownership.xml…